SCHEMBL15065579

SCHEMBL15065579

O=C(O)N1CCNC(c2ccc3cc(-c4nc5ccccc5s4)c(=O)oc3c2)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.56
▸ PIK3CB P42338 1/20 0.56
▸ ALK Q9UM73 2/20 0.43
▸ NPC1 O15118 6/20 0.38
▸ RAB9A P51151 6/20 0.38
▸ MAPT P10636 5/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ PKM P14618 1/20 0.38
▸ GLA P06280 4/20 0.37
▸ SMN1; SMN2 Q16637 5/20 0.36
▸ KDM4E B2RXH2 5/20 0.36
▸ HPGD P15428 4/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ATM Q13315 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ GAA P10253 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ APP P05067 1/20 0.36
▸ USP2 O75604 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16826535 0.83 IRAK4 (0.37) PIK3CDPIK3CBNPC1RAB9AMAPT
SCHEMBL15086130 0.76 PIK3CD (0.58) PIK3CDPIK3CBALKNPC1RAB9A
SCHEMBL22372346 0.75 PIK3CD (0.62) PIK3CDPIK3CBALKNPC1RAB9A
SCHEMBL22372341 0.74 PIK3CD (0.57) PIK3CDPIK3CBALKNPC1RAB9A
SCHEMBL30165793 0.74 PIK3CD (0.57) PIK3CDPIK3CBALKNPC1RAB9A
SCHEMBL22372335 0.73 PIK3CD (0.59) PIK3CDPIK3CBALKNPC1RAB9A
SCHEMBL21485987 0.73 PIK3CD (0.54) PIK3CDPIK3CBALKNPC1RAB9A
SCHEMBL29524563 0.73 PIK3CD (1.00) PIK3CDPIK3CBALKNPC1RAB9A
SCHEMBL592311 0.73 PIK3CD (1.00) PIK3CDPIK3CBALKNPC1RAB9A
SCHEMBL29427470 0.73 PIK3CD (1.00) PIK3CDPIK3CBALKNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015095449-A1 METHODS FOR MODULATING THE AMOUNT RNA TRANSCRIPTS PTC THERAPEUTICS, INC. (US) 2015-06-25 — — WO claimed
EP-2797592-A1 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY PTC Therapeutics, Inc. (US) 2014-11-05 — — EP claimed
WO-2013101974-A1 COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY PTC THERAPEUTICS, INC. (US) 2013-07-04 — — WO claimed
WO-2015095449-A1 METHODS FOR MODULATING THE AMOUNT RNA TRANSCRIPTS PTC THERAPEUTICS, INC. (US) 2015-06-25 — — WO disclosed
Send feedback